# Filing Detail

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-24-034898
Filing Date
2024-09-04
Accepted
2024-09-03 21:51:36
Documents
87
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-ka.htm iXBRL | 10-K/A | 2889980
2 |  | ex21.htm | EX-21 | 2394
3 |  | ex23-1.htm | EX-23.1 | 3699
4 |  | ex31-1.htm | EX-31.1 | 11753
5 |  | ex31-2.htm | EX-31.2 | 12419
6 |  | ex32-1.htm | EX-32.1 | 6784
7 |  | ex32-2.htm | EX-32.2 | 6904
8 |  | form10-k_001.jpg | GRAPHIC | 27071
9 |  | form10-k_002.jpg | GRAPHIC | 106726
10 |  | form10-k_003.jpg | GRAPHIC | 20538
11 |  | form10-k_004.jpg | GRAPHIC | 20085
12 |  | form10-k_005.jpg | GRAPHIC | 155967
| Complete submission text file | 0001493152-24-034898.txt |  | 13121215

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
13 | XBRL SCHEMA FILE | shph-20231231.xsd | EX-101.SCH | 76094
14 | XBRL CALCULATION FILE | shph-20231231_cal.xml | EX-101.CAL | 79308
15 | XBRL DEFINITION FILE | shph-20231231_def.xml | EX-101.DEF | 419505
16 | XBRL LABEL FILE | shph-20231231_lab.xml | EX-101.LAB | 614024
17 | XBRL PRESENTATION FILE | shph-20231231_pre.xml | EX-101.PRE | 519809
90 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-ka_htm.xml | XML | 2041909

Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41488 | Film No.: 241275758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)